RESULTS: All the patients have significant hematological response, clinical symptoms have different degrees of improvement, some patients were eased.
结果所有患者都有明显血液学反应，临床症状有不同程度的改善，部分患者获得缓解。
The regimen could be well tolerated, and the major adverse reactions were infusion-related response (32%) and hematological toxicities (20%).
主要不良反应为输注相关的不良反应（32 % ）和化疗相关的血液学毒副反应（2 0 % ）。
The regimen could be well tolerated, and the major adverse reactions were infusion-related response (32%) and hematological toxicities (20%).
主要不良反应为输注相关的不良反应（32 % ）和化疗相关的血液学毒副反应（2 0 % ）。
应用推荐